Back

Natural compounds to treat cardiac fibrosis.

25 May 2019 (11:30 - 11:45)
Organised by:
Congress Presentation Part of: Anti-fibrotic therapies in heart failure. Cardiac Diseases HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)

3 More presentations in this session

Presentation thumbnail
Myocardial fibrosis: new concepts.
Professor S. Heymans (Maastricht, NL)
Slides Video
Presentation thumbnail
Targeting the cellular origin of cardiac fibrosis.
Professor J. Hulot (Paris, FR)
Slides Video
Presentation thumbnail
Clinical value of anti-fibrotic strategies.
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Slides Video

Access the full session

Session thumbnail
Anti-fibrotic therapies in heart failure.

The Event

Event poster

Heart Failure 2019

25 May 2019 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Natural history of myocardial fibrosis in dilated cardiomyopathy
28 August 2022
thumbnail
Congress Presentation
Polydatin, a nutraceutical agent, reduces cardiotoxicity and enhances the anticancer effects of Sunitinib through the reduction of lipid peroxidation and expression of NLRP3 inflammasome
29 June 2021
thumbnail
Congress Presentation
Quercetin blocks senescence-related cardiorenal fibrosis induced by hypertension
1 September 2025
thumbnail
Congress Presentation
Mechanisms involved in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity
20 April 2018

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources